SLG
CYAD

Stanley-Laman Group’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Stanley-Laman Group’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-39,750
Closed -$1.05M – 303
2018
Q3 		$1.05M Buy
39,750
+1,225
+3% +$35.9K 0.26% 121
2018
Q2 		$1.15M Buy
+38,525
New +$1.18M 0.26% 110

Other funds holding CYAD

Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

Stanley-Laman Group's CYAD Position: Q4 2018 in Review

Stanley-Laman Group sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q4 2018, closing a stake of 39,750 shares — an estimated $1.05M sold.

Stanley-Laman Group first reported a position in CYAD in Q2 2018 and held it in 2 quarters. The position peaked at $1.15M in Q2 2018. 8 funds tracked by Wall St. Rank hold CYAD as of Q4 2018.

  • Stanley-Laman Group reported no remaining Celyad Oncology SA American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Stanley-Laman Group sold 39,750 Celyad Oncology SA American Depositary Shares shares in Q4 2018, an estimated $1.05M.
  • Stanley-Laman Group first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2018 and held it in 2 quarters.
  • Stanley-Laman Group's Celyad Oncology SA American Depositary Shares position peaked at $1.15M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q4 2018.

Based on Stanley-Laman Group's 13F filing for Q4 2018, filed 7 Feb 2019.